Msicspharma
1 known investors
Find your way into Msicspharma
387 people in our graph share verified history with the Msicspharma team — schools, employers, funds. One of them is your warm intro.
Lisa Cohenunlockedknows Omer Zerahia · together at The Hebrew University of Jerusalem (overlapped)
×9knows the team · via Tel Aviv University
×2knows the team · via The Hebrew University of Jerusalem
MSICS Pharma develops naturally-sourced psilocybin products for pharmaceutical use, operating a GMP production facility that produces its flagship product MSX-06. The product is undergoing clinical trials with hospitals to treat mental health conditions including depression, OCD, anxiety, PTSD, and eating disorders.
Founders & leadership
RZ
Roei ZerahiainCo-Founder & CEORoei Zerahia is founder of MSICS Pharma, which develops psilocybin products for clinical psychiatric applications. He previously served as CEO of Canndoc, a pharmaceutical-grade cannabis company, from 2012 to 2020, and held senior management roles in the medical cannabis sector before transitioning to psychedelics.
OZ
Omer ZerahiainCo Founder & CBOOmer Zerahia is co-founder and chief business officer of MSICS Pharma, which develops psilocybin-based treatments for mental health conditions. He previously served as executive vice president at Canndoc, a publicly traded cannabis company, where he led its IPO and international expansion across North America and Europe.
Investors · 1
Frequently asked questions
- What does Msicspharma do?
- MSICS Pharma develops naturally-sourced psilocybin products for pharmaceutical use, operating a GMP production facility that produces its flagship product MSX-06. The product is undergoing clinical trials with hospitals to treat mental health conditions including depression, OCD, anxiety, PTSD, and eating disorders.
- Who founded Msicspharma?
- Msicspharma was founded by Roei Zerahia, Omer Zerahia.
- Who are Msicspharma's investors?
- Msicspharma's investors include Fusion VC.